论文部分内容阅读
本文报道用抗乙肝免疫核糖核酸（ＩＲＮＡ）加乙肝疫苗治疗慢性乙型肝炎及慢性乙肝病毒携带者（２０例）有较好抗病毒作用，特别是对ＨＢｅＡｇ转阴效果最佳，阴转率为８５％，与用转移因子（ＴＦ）对照组相比明显高于后者（Ｐ＜０．０１）；并有促进ＨＢｓＡｂ生成的远期效果。
In this paper, IRNA and hepatitis B vaccine treatment of chronic hepatitis B and chronic hepatitis B virus carriers (20 cases) have better antiviral effect, especially for HBeAg negative best negative conversion rate was 85%, which was significantly higher than that of the control group (P <0.01) and the long-term effect of promoting HBsAb production.